Cargando…

Nutritional and immunological parameters as prognostic factors in patients with advanced oral cancer()

OBJECTIVE: The aim of the present study was to analyze the prognostic relationship of weight loss and preoperative hematological indexes in patients surgically treated for pT4a squamous cell carcinoma of the oral cavity. METHODS: A retrospective cohort study. RESULTS: Percent weight loss greater tha...

Descripción completa

Detalles Bibliográficos
Autores principales: Trevisani, Lorenzo Fernandes Moça, Kulcsar, Isabelle Fernandes, Leite, Ana Kober Nogueira, Kulcsar, Marco Aurélio Vamondes, Lima, Graziele Aparecida Simões, Dedivitis, Rogerio Aparecido, Kowalski, Luiz Paulo, Matos, Leandro Luongo
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9756066/
https://www.ncbi.nlm.nih.gov/pubmed/35277368
http://dx.doi.org/10.1016/j.bjorl.2021.11.003
Descripción
Sumario:OBJECTIVE: The aim of the present study was to analyze the prognostic relationship of weight loss and preoperative hematological indexes in patients surgically treated for pT4a squamous cell carcinoma of the oral cavity. METHODS: A retrospective cohort study. RESULTS: Percent weight loss greater than 10% was identified in 49 patients (28.2%), and any weight loss in relation to the usual weight occurred in 140 patients (78.7%). Percent weight loss greater than 10% (HR = 1.679), Red cell distribution width (RDW) values greater than 14.3% (HR = 2.210) and extracapsular spread (HR = 1.677) were independent variables associated with risk of death. CONCLUSION: Patients with advanced squamous cell carcinoma of the oral cavity present significant weight loss and as significantly immunocompromised. Increased values of RDW and higher percentages of weight loss in relation to the individual's usual weight, together with extracapsular spread of metastatic lymph nodes, were risk factors for lower survival, regardless of other clinical and anatomopathological characteristics. LEVEL OF EVIDENCE: 3.